Literature DB >> 12796252

Large-spot size transpupillary thermotherapy for the treatment of occult choroidal neovascularization associated with age-related macular degeneration.

Allen B Thach1, Jack O Sipperley, Pravin U Dugel, Scott R Sneed, Donald W Park, Jennifer Cornelius.   

Abstract

OBJECTIVE: To describe the outcome of patients with occult choroidal neovascularization in age-related macular degeneration treated with transpupillary thermotherapy.
DESIGN: Prospective, nonrandomized, nonmasked case series.
METHODS: All patients with age-related macular degeneration with a predominantly occult choroidal neovascular membrane and an initial visual acuity of 20/400 or better were offered treatment using transpupillary thermotherapy. The treatment consisted of using a diode laser, a spot size of about 3000 to 6000 micro m delivered over 60 seconds, and a power of 600 to 1000 mW. MAIN OUTCOME MEASURES: A stable, improved, or worsened visual acuity and the need for additional treatment.
RESULTS: Sixty-nine patients were treated. All patients have been followed up for at least 6 months. At the 6-, 9-, and 12-month follow-up visits, 71% of patients have stable or improved visual acuity and 29% have lost 2 or more lines of visual acuity on the Snellen letter chart.
CONCLUSION: Large-spot size transpupillary thermotherapy is effective in stabilizing the visual acuity in those patients who have occult choroidal neovascularization due to age-related macular degeneration.

Entities:  

Mesh:

Year:  2003        PMID: 12796252     DOI: 10.1001/archopht.121.6.817

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Chorioretinal temperature monitoring during transpupillary thermotherapy for choroidal neovascularisation.

Authors:  S Miura; H Nishiwaki; Y Ieki; Y Hirata; Y Honda; Y Sugino; Y Okazaki
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

2.  Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trial.

Authors:  U Stolba; I Krebs; P D Lamar; T Aggermann; D Gruber; S Binder
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 3.  Current and future treatment options for nonexudative and exudative age-related macular degeneration.

Authors:  Grant M Comer; Thomas A Ciulla; Mark H Criswell; Michael Tolentino
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  [Transpupillary thermotherapy for occult choroidal neovascularizations].

Authors:  U Weber; H Hecker
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

5.  Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].

Authors:  Ricardo Agurto-Rivera; Jose Diaz-Rubio; Luis Torres-Bernal; Tamer A Macky; Juner Colina-Luquez; Gabriela Papa-Oliva; Rama D Jager; Susana Martinez-Jardon; Jans Fromow-Guerra; Hugo Quiroz-Mercado
Journal:  BMC Ophthalmol       Date:  2005-11-25       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.